Literature DB >> 1873976

In vitro susceptibilities of Edwardsiella tarda to 22 antibiotics and antibiotic-beta-lactamase-inhibitor agents.

R B Clark1, P D Lister, J M Janda.   

Abstract

The in vitro susceptibilities of 22 isolates of Edwardsiella tarda were studied with 22 antibiotics and antibiotic-beta-lactamase-inhibitor agents. Results indicated that all isolates were susceptible to the aminoglycosides, cephalosporins, penicillins, imipenem, aztreonam, ciprofloxacin, and antibiotic-beta-lactamase-inhibitor agents. Each strain produced a beta-lactamase even though no resistance was detected to the beta-lactams.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1873976     DOI: 10.1016/0732-8893(91)90054-j

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

Review 1.  Edwardsiellosis in fish: a brief review.

Authors:  B R Mohanty; P K Sahoo
Journal:  J Biosci       Date:  2007-12       Impact factor: 1.826

2.  Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae.

Authors:  I Stock; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 3.  Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; R N Brogden
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

4.  Edwardsiella tarda Bacteremia, Okayama, Japan, 2005-2016.

Authors:  Shinya Kamiyama; Akira Kuriyama; Toru Hashimoto
Journal:  Emerg Infect Dis       Date:  2019-10       Impact factor: 6.883

Review 5.  Mycotic aneurysm caused by Edwardsiella tarda successfully treated with stenting and suppressive antibiotic therapy: a case report and systematic review.

Authors:  Kei Furui Ebisawa; Sho Nishimura; Shungo Yamamoto; Goh Ohji; Kentaro Iwata
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-05-10       Impact factor: 3.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.